TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| Pinnacol probe resumes at Colorado Capitol Injured workers who claim they were unfairly denied payment by Pinnacol Assurance, Colorado’s largest workers-compensation insurer, told their stories to a legislative committee Monday at the state Capitol. feeds.bizjournals.com |
Tax on 'Cadillac' Plans Draws Flak Labor unions and some Democrats are pushing to scale back a proposal in the latest version of Senate health-overhaul legislation that would tax generous insurance plans. online.wsj.com |
Boys' Use Of Gardasil Is Approved The vaccine Gardasil won regulators' approval for use in males, setting the stage for a debate over whether boys should routinely receive an inoculation used to prevent cervical cancer in women. online.wsj.com |
Number of Insured Varies by Bill When the Senate unveils its health-care bill, all eyes will be on the price tag. But an equally significant number may be how many people get insurance. online.wsj.com |
A Window of Opportunity to Buy Emisphere Joseph Ramelli submits:When Emisphere's (EMIS) news release entitled "Emisphere Technologies Reports DMC Recommendation to Proceed with Phase 3 Clinical Trials with Oral Calcitonin for Osteoporosis and Osteoarthritis" hit the wires last week, it was the single biggest event in the company's history. If you weren't already totally up on the story the significance probably would have been lost on you. The Data Monitoring Committee based their recommendation to proceed upon "an assessment of safety and efficacy parameters." Translation: that the drug is safe (should come as no surprise to anyone that read my previous articles) and that we are hitting our primary endpoints in both trials. This was absolutely huge news, which we greeted with open buy orders. It is my opinion that it is no longer a question of whether Oral Calcitonin will be approved for both indications or not; it is merely a question of timing, and the timing of approvals might be sooner than most are expecting.Complete Story » seekingalpha.com |